Company: RVRC
Filing Date: 2025-10-03
Form Type: S-1/A
Source: 0001213900-25-096094
Chunk: 184

Company: Revium Rx.
Filing Date: 2025-10-03
Form: S-1/A
Chunk 184
---
,562,500 | -7 |     |                    |  5.8 | % |     |          |  5.5 | % |

| * | Less than 1% |

| (1) | Includes (i) 2,800,000                                                                                                                
 common stock, and (ii) 2,202,500 shares of Common Stock issuable upon exercise of vested stock options and options exercisable within 
 60 days from the date of this Prospectus.                                                                                             |

| (2) | Represents shares of Common Stock issuable upon                                                                                                                                                     
 exercise of vested stock options and options exercisable within 60 days from the date of this Prospectus.                                                                                           |
| (3) | Includes (i) 3,687,189 common stock, and (ii) 690,000 shares of Common Stock issuable upon exercise of vested stock options and options exercisable within 60 days from the date of this Prospectus |

| (4) | Includes 5,840,000 common stock. David Safren has the sole voting and investment power over the shares held by SBDHEI LP |

| (5) | Includes (i) 5,785,410 common stock, and (ii) 1,171,875 shares of Common Stock issuable upon exercise of warrants, exercisable within 60 days from the date of this Prospectus. Yitzchak Rokovsky has the sole voting and investment power over the shares held by Third Eye Investors LLC. |

| (6) | Includes (i) 3,969,890 common stock, and (ii) 781,250 shares of Common Stock issuable upon exercise of warrants exercisable within 60 days from the date of this Prospectus. |

| (7) | Includes (i) 2,375,000                                                                                                              
 common stock, and (ii) 1,187,500 shares of Common Stock issuable upon exercise of warrants exercisable within 60 days from the date 
 of this Prospectus.                                                                                                                 |

<div align='center'>113

CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS</div>

Related Party Transactions

The following is a description of transactions since January 1, 2023, to which we were a party or will be a party, in which the amount involved exceeded or will exceed the lesser of $120,000 or 1% of the average of our total assets at year-end for the last three completed fiscal years, and